trial results of venetoclax plus chop therapy with rituximab or obinutuzumab in non-hodgkin lymphoma
Published 7 years ago • 210 plays • Length 3:42Download video MP4
Download video MP3
Similar videos
-
1:55
unmet needs in dlbcl: frontline therapy, car-t optimization, and clinical trial inclusion
-
2:04
results of trial of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in cll
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:43
eradic trial: preliminary results of mrd-guided ibrutinib plus venetoclax vs fcr
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
6:37
brecadd regimen is superior in treating advanced hl: results from the hd21 trial
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:36
cll2-give trial: ibrutinib, venetoclax and obinutuzumab in patients with tp53-mutated cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
2:08
the venice-1 trial: venetoclax monotherapy in r/r cll
-
2:13
venetoclax rituximab for r/r cll: 7-year results of the murano trial
-
2:09
overview of the cll13 trial: replacing chemotherapy with venetoclax-containing regimens
-
0:58
the impact of the clinical trial of venetoclax (abt-199) and obinutuzumab in cll
-
2:58
long-term updates from the reach trial of hydroxyurea in pediatric patients with scd in ssa
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml